Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease

PURPOSE OF REVIEW: Diabetic kidney disease (DKD), a leading cause of end-stage kidney disease, is the result of metabolic network alterations in the kidney. Therefore, metabolomics is an effective tool for understanding its pathophysiology, finding key biomarkers, and developing a new treatment stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Sho, Inagi, Reiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Microvascular Complications—Nephropathy (B Roshanravan, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113300/
https://www.ncbi.nlm.nih.gov/pubmed/33974145
http://dx.doi.org/10.1007/s11892-021-01390-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113300/
https://www.ncbi.nlm.nih.gov/pubmed/33974145
http://dx.doi.org/10.1007/s11892-021-01390-8

Ejemplares similares